Recent News

• 08.05.2026 - KORU Medical Systems Announces Second Quarter 2026 Results and Updates Full Year 2026 Guidance
• 07.29.2026 - KORU Medical Systems to Participate in the Canaccord Genuity 46th Annual Growth Conference
• 07.15.2026 - KORU Medical Systems to Report Second Quarter 2026 Financial Results on August 5, 2026
• 05.18.2026 - KORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51st Annual Oncology Nursing Society Congress
• 05.06.2026 - KORU Medical Systems Announces First Quarter 2026 Results
• 04.16.2026 - KORU Medical Systems to Report First Quarter 2026 Financial Results on May 6, 2026
• 03.13.2026 - KORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe Compatibility
• 03.12.2026 - KORU Medical Systems Announces CEO Transition
• 03.12.2026 - KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance
• 02.26.2026 - KORU Medical Systems to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

Recent Filings

• 08.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.05.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.05.2026 - 8-K Current report
• 08.03.2026 - 144 Report of proposed sale of securities
• 07.29.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 07.13.2026 - 4/A Statement of changes in beneficial ownership of securities
• 07.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 07.01.2026 - 4 Statement of changes in beneficial ownership of securities
• 07.01.2026 - 4 Statement of changes in beneficial ownership of securities
• 07.01.2026 - 4 Statement of changes in beneficial ownership of securities